PellevĂ© ‘party-ready’ skin tightening treatment launched in UK

A new non-invasive treatment claims to give you smoother and tighter skin without injections and anaesthetic.

Pelleve_Before_and_Immediately_After_Treatment [320x200].jpgPellevĂ©TM  is being promoted as a way to make yourself look younger and refreshed instantly.

How does it work?

PellevéTM heats the top layers of your skin using advanced radiowave technology without damaging the epidermis. The heat causes the collagen in your skin to contract and tighten, giving an immediate improvement to your skin: it also promotes the production of new collagen. This means you will notice the improvement in your skin quality and firmness over a number of weeks, or even months. The pictures above show the before and after of an eye and mouth treatment.Eyes

PellevéTM can be used on a number of areas, including:

– Skin under the chin
– Wrinkles around the mouth
– Lines on the forehead, including those in and around the eyebrows
– Crows feet
– Excess skin on upper eyelid

The best thing about PellevĂ©TM is the immediate improvement to your skin, without the usual pain and irritations. We watched a treatment being done and then had an opportunity to experience it ourselves – on one hand! Your skin is heated to around 40°C and then cooled, which is repeated several times for maximum effect.  It wasn’t an unpleasant feeling at all!

The cost of the treatment starts from about ÂŁ600.

We will be featuring a full review of this new treatment soon, so be sure to check back to learn more.

In the meantime, why not have a look at www.pelleve.com?

Do your bit for menopausal women….

Kings College

guys and st thomas.jpg

 

 

 

Have you been diagnosed with premature ovarian failure (early menopause) within the last three years? If so, you could help to find a treatment for future generations… and maybe improve your own life a little!

Premature ovarian failure affects one in 20 women under 45.  It is estimated that there are more than 7,000 women with premature ovarian failure living in the London boroughs of Lambeth and Southwark alone. . 

It is a devastating diagnosis because it causes unpleasant menopausal symptoms, long term health risks, and greatly reduces the chance of becoming pregnant naturally.  Very little research into the condition has been carried out.

The female hormone Oestrogen is used as a ‘replacement’ treatment, to boost low levels in the body, which in turn alleviates symptoms of the menopause. However, it is not known what the ‘best’ treatment is and the effects of taking no treatment are also unknown.

But that is about to change…

Doctors and researchers at Guy’s Hospital and King’s College London are looking for women aged between 18-44 years who have been diagnosed with premature ovarian failure (early menopause) within the last three years, to participate in a research study to help find out more about the best treatment for the condition and the exact effects of no treatment.

The study at Guy’s Hospital will compare the effects of active treatment with either hormone replacement therapy or the combined oral contraceptive pill, or no treatment, and will involve approximately 70 women.

Katy Hayward from Lancashire is one of the women taking part in the study.  She was diagnosed with premature ovarian failure last year at 28 years old.  She said:  “I discovered I had gone through an early menopause a year ago and found myself searching for answers.  I realised that by participating in research I can help researchers find the best ways to manage premature ovarian failure, and hopefully help improve health care services provided for women in my position in future.”

Details of the study and how to take part

Dr Beth Cartwright, from the Menopause Research Unit at Guy’s Hospital said: “Local women can help us to extend understanding of the early menopause by taking part in this important research study.  They can choose whether to take treatment or not. 

Through a number of tests, scans and questionnaires over a two year period, we will compare the effects of the different treatments and the no treatment option on bone health, cardiovascular health, sexual function, symptom control, psychological wellbeing and overall quality of life. 

All women taking part will receive comprehensive care relevant to their premature ovarian failure and their participation will help in the treatment of early menopause in the future.”

Participation in the study involves seven visits to the Menopause Research Unit at Guy’s hospital over a two year period.

This includes;

– a screening visit to check eligibility to enrol
– DXA bone scans to monitor bone density
– ultrasound scans to look at the ovaries
– blood tests 

These investigations are carried out at enrolment and after six, 12 and 24 months. 

The DXA bone scan involves a very small amount of radiation which is similar to two days’ exposure to everyday background radiation.  The blood test and ultrasound scan may cause slight discomfort.

For further information about the study, contact Dr Beth Cartwright in the Menopause Research Unit at Guy’s Hospital on 020 7188 3024 or email: beth.cartwright@kcl.ac.uk.  By contacting the unit you are not obliged to take part.

MS sufferer campaigns to increase awareness of addiction drug

image
image

MS sufferer Linda Elsegood (pictured right) could not see or hear properly and had to use a wheelchair before she discovered Low Dose Naltrexone (LDN). Now she has launched her own campaign to increase awareness of the possible use of the drug in MS treatment.

Linda was so crippled by the disease that she was barely able to attend her daughterÂ’s wedding. Then LindaÂ’s life was transformed when she discovered LDN via the internet.

“The MS was causing me excruciating pain. It started with a tingling on my tongue, then I just couldn’t get out of bed and was sleeping for 20 hours a day,” says Linda, from Norfolk.

“I was finally diagnosed with Relapsing and Remitting MS. In October 2003, my neurologist told me there was nothing more that could be done for me.”

From that moment LindaÂ’s deterioration was rapid until she started taking LDN in December 2003 and noticed improvements after three weeks. This continued for two years and then LindaÂ’s symptoms stabilised.

LDN uses approximately 1% of the Naltrexone dose approved by the Food and Drug Administration (FDA) for treating alcoholism and drug addiction.

“I still have MS but life is good,” says Linda. “I can set targets and achieve them and look forward to the future.

“The other prescribed treatments had horrendous side effects and cannabis was not an option for me.

“After my success with LDN, I wanted everyone to know about it. I formed the LDN Research Trust in May 2004 and now spend all my time helping others while trying to raise funds for clinical trials.”

“Naltrexone is a generic drug that is out of patent, so very cheap to produce. The downside of that is that drug companies will not fund trials as there is no money to be made.

“I’d like the Government to fund clinical trials as I believe this could change the lives of thousands of people in the UK who suffer not only from MS but also Crohn’s, cancer and other diseases.”

The LDN Research Trust website www.ldnresearchtrust.org offers information for anyone considering the treatment.

The first International LDN Awareness Week takes place from October 19-25, 2009.

Linda is pictured, right, with her grandson Leo.

image

Whitening (Barrier) – Animation and Qs & As

image

BARRIER WHITENING

Q What does tooth whitening do?

A Tooth whitening can be a highly effective, yet very simple way, of lightening the colour of teeth without removing any of the tooth surface. It cannot make a colour change, but lightens the existing colour.

Q What does the procedure involve?

A The dentist applies a chemical barrier to the gums, which will protect them during the whitening process. The whitening solution is then applied to the teeth and the chemical is then activated using heat, or heat and light combined.
Once the whitening process is finished the barrier will be easily removed in one piece.

If the tooth has been root treated, the canal, which previously contained the nerve, may be reopened and the whitening product is put in.

Q How long does the procedure take?

A The process would normally take over an hour but your dentist will advise you on your specific requirements.

Q Will I be happy with the results?

A Treatment results may vary depending on the original shade of the teeth. Teeth will tend to darken slightly over time. The effect lasts for around 1 to 3 years, although sometimes it can last longer.

Q When might whitening not work?

A Whitening can only lighten your existing tooth colour. For a change to specific chosen shade veneering is another option. Whitening also works on natural teeth. It will not work on any type of ‘falseÂ’ teeth. This includes dentures, crowns and veneers. If dentures are stained or discoloured, it may be worth visiting the dentist and asking him or her to clean them. Stained veneers, crowns and dentures may need replacing. Again, ask your dentist.

Q How do I care for my teeth after whitening?

A Talk to your dentist about maintaining the colour of your teeth, and the products that are available for keeping the effect. Each individualÂ’s lifestyle needs to be assessed but good oral hygiene and regular visits to the hygienist will help to maintain the effect for longer.

Some people find that their teeth are sensitive for the first few days after treatment, but this wears off after a short while. Your dentist will advise you of the products you can use to counteract this.

Diabetes sufferers must ask questions

image

London: Over three quarters (78%) of two million people diagnosed with diabetes1 in the UK donÂ’t receive any information on their medicines when they are given a new prescription and 36% donÂ’t know what questions to ask about their treatment options.2

Partly as a result of missing information, nearly two thirds (65%) of people with diabetes are not taking their medications as prescribed, and one in three people donÂ’t understand what their diabetesmedications are for or how to take them because they feel stupid asking

questions.2

Therefore, in order to empower people with diabetes to communicate with their healthcare professional and help improve their understanding of medicines, two new resources have been made available by a partnership of Ask About Medicines, the Association of the British Pharmaceutical Industryand Diabetes UK.

A booklet, Ask About Your Diabetes Medicines,contains questions that people might want to ask healthcare professionals involved in their treatment throughout their diagnosis and treatment. It also signposts people to further sources of information, including patient-friendly Medicine Guides for Diabetes www.medicines.org.uk.

The new Medicine Guides provide easy-to-understand information about every diabetes medicine to help people use them safely and effectively, and make better informed choices about treatment, with their health professional.

The Medicine Guides have been developed as part of the Medicines Information Project (MIP), which is creating a new comprehensive, structured source of information about medicines alongside information about the condition and all the treatment options. Medicine Guides are linked to information about the condition and the range of treatment options available, provided via NHS Direct Online.

These two resources aim to help people make better informed choices about treatment, with their health professional, and to understand and use their medicines safely and effectively.

Simon O’Neill, Director of Care and Policy at Diabetes UK, commented, “It is vital that people with diabetes are empowered and encouraged to ask questions. 95% of diabetes management is self care, so failing to understand or take medicines could be fatal. Our research suggests that many people don’t know what questions to ask which is why we have developed this simple but powerful tool. Alongside the new medicine guide resource, this should mean that people with diabetes are able to ask
for and receive the right I information about their condition and treatment.”

To obtain a copy of the Ask About Your Diabetes Medicines booklet please visit www.askaboutmedicines.org For more information about Diabetes please call the Diabetes UK Careline on 0845 120 2960 or visit www.diabetes.org.uk

References:
1. Boyle DIR et al. A record linking capture-recapture technique to create a diabetes disease register for epidemiological research, 1998 2. Research Now conducted the Diabetes Information Jigsaw Survey among 505 people with diabetes, June 2006.

Notes to editors:

www.medicines.org.uk or via the NHS
Direct Online website at Ask About Medicines www.askaboutmedicines.orgis the independent campaign to increase people’s involvement in decisions about their use
of medicines.

Diabetes UK www.diabetes.org.uk is the largest organisation in the UK working for people with diabetes, funding research, campaign and helping people live with the condition. It has over 170,000 members and is working for people with diabetes, their carers, family and friends. The organisation represents the interest of people with diabetes by lobbying the government for better standards of care and the best quality of life. Diabetes UK spends over ÂŁ6 million on research every year to improve the treatment of diabetes and hope that their research will ultimately lead to finding a cure for diabetes. Diabetes UKÂ’s mission is to improve the lives of people with diabetes and to work towards a future without diabetes.

The Association of the British Pharmaceutical Industry www.abpi.org.ukis the trade association for some 75 companies in the UK that produce prescription medicines. As part of their role they have encouraged Datapharm to develop medicines information for patients which is available online at www.medicines.org.uk

Type ll diabetes – there is a cure for this lifestyle disease..

London: A respected and fully licensed private clinic that specialises in treating an array of illnesses by rebalancing the body at a cellular level has successfully cured more than 200 patients suffering from Type 11 diabetes.

Now the clinic is looking for three UK patients that it is offering to treat on a complementary basis in exchange for their story in a case study for the media – this would include interviews and photos. Patients who take part must be willing to have the story of their cure published exclusively in the first instance in ELIXIR, the new glossy magazine on healthy ageing.

The treatment which is bespoke and unique is not experimental and does not involve the use of any unlicensed or unproven drugs. This is not a patient trial or an experiment and it is not a drug therapy.

The clinic, which is outside of the UK, is planning to offer this treatment in Britain.

The treatment which the patients would receive focuses on rebalancing the whole body at a cellular level, including restoring the optimum function of all the vital organs. This allows the body to heal itself. The end result is that patients will usually loose weight, the pancreas starts to produce normal insulin flows and the body eventually reacts normally to insulin. As a side effect the treatment also turns the body clock back by five years.

This treatment is intense and requires the patient to be away from home for three weeks. It is carried out in three phases – detox, repair and renewal. The patient sees a doctor every day, spending three hours daily in the clinic. The rest of the time can be spent as a tourist providing no alcohol is consumed. The patient stays in a nearby hotel.

These advanced diagnostics are to discover what in addition to diabetes is influencing the bodyÂ’s health. This clinic probably has more state of the art diagnostics than any other clinic in the world, including from the US and Europe. The doctors are the best in the country and have the highest medical qualifications and include endrocrinologists.

The tests they will take look at the health of every organ, its functional level, hormones, cardiovascular health and include a detailed analysis of the blood to determine whether the body has infections such as parasites, HIV or hepatitis.

Included are the following
• Ultra sound radio wave scan
• ECG heart scan
• Cellular energy scan of all the body’s vital organs
• Cardio vascular system scan

As a result of the findings the doctors create the bespoke three step programme which is administered via intravenous drip for between three to four hours a day. During this time the patient can read or listen to music on an IPOD for example. An intravenous drip is used because the therapy is more efficient and without side effects such as nausea since it bypasses the stomach.

The treatment starts to work with three days but some patients see an improvement within hours as insulin levels plummet. Patients are required to wear a monitor which tests their blood sugar every three minutes.

The treatment programme has an effect not only on the principle illness but on the metabolism. When the function of an organ is returned to normal the body rids itself of everything it doesnÂ’t need, like plaque and toxins. The body starts to heal itself and the doctor just helps in the process

In the first phrase of treatment patients are detoxed and cleansed and particular attention is given to the ph (acid versus alkaline) composition of their blood. This cleansing of the body is energising and assists the next stage.

In the second phase therapeutic treatments are administered which may include antibiotics and other drugs. The issue of sugar and how the body deals with carbohydrate is also corrected and patients may be able to withdraw from insulin use if the pancreas is sufficiently stimulated.

In the third phase an array of pleasant treatments to stimulate well-being are used including massage. Patients may also be assisted with stress management techniques. This phase may include complementary therapies such as hydro-colonic therapy.

To receive this treatment is a unique opportunity and a privilege and would cost many thousands of pounds.

The clinic does treat Type 1 diabetes but on this occasion is looking for adults who have been diagnosed with Type 11. Patients suffering from cancer and cancer-related illnesses are also not suitable for this case study.

Patients will have to pay their own air fare (within Europe) and all their own expenses outside of the bespoke hospital programme. You must be willing to have your personal story told in the media together with photos.Three patients will be chosen and they will go to treatment as soon as is convenient.

If you would like to be selected for this bespoke treatment please contact us by email at communications@elixir-media.com.

Disclaimer: Elixir News is not endorsing any treatments and therapies offered but is independently reporting the story of what appears to be a remarkable step forward in the treatment of diabetes through painstaking diagnositics and treatments not available anywhere else.